- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-576/19 P: Judgment of the Court (Ninth Chamber) of 29 October 2020 — Intercept Pharma Ltd, Intercept Pharmaceuticals Inc. v European Medicines Agency (Appeal — Access to documents of the institutions, bodies, offices or agencies of the European Union — Regulation (EC) No 1049/2001 — Second indent of Article 4(2) — Exception relating to the protection of court proceedings — First indent of Article 4(2) — Exception relating to the protection of commercial interests — Documents submitted in the context of a marketing authorisation application for a medicinal product for human use — Decision to grant a third party access to the documents)
ECLI:EU:UNKNOWN:62019CA0576
62019CA0576
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
14.12.2020
Official Journal of the European Union
C 433/13
(Case C-576/19 P) (*)
(Appeal - Access to documents of the institutions, bodies, offices or agencies of the European Union - Regulation (EC) No 1049/2001 - Second indent of Article 4(2) - Exception relating to the protection of court proceedings - First indent of Article 4(2) - Exception relating to the protection of commercial interests - Documents submitted in the context of a marketing authorisation application for a medicinal product for human use - Decision to grant a third party access to the documents)
(2020/C 433/14)
Language of the case: English
Parties
Appellants: Intercept Pharma Ltd, Intercept Pharmaceuticals Inc. (represented by: L. Tsang, Solicitor and F. Campbell, Barrister and by J. Mulryne and E. Amos, Solicitors)
Other party to the proceedings: European Medicines Agency (represented by: T. Jabłoński, S. Drosos, R. Pita, S. Marino and H. Kerr, acting as Agents)
Operative part of the judgment
The Court:
1.Dismisses the appeal;
2.Orders Intercept Pharma Ltd and Intercept Pharmaceuticals Inc. to bear their own costs and to pay those incurred by the European Medicines Agency (EMA).
(*) Language of the case: English.
(1) OJ C 432, 23.12.2019.